Gov't Bid To Undo Arthrex-Based Remand Flops At Fed. Circ.
The full Federal Circuit has left in place a panel decision vacating the Patent Trial and Appeal Board's invalidation of a technology licensing company's patent, shrugging off warnings from the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article